PharmaCyte Biotech Enters into License Agreement for COVID-19 Diagnostic Kits

LAGUNA HILLS, Calif.–(BUSINESS WIRE)– #INDstatus–PharmaCyte has entered into an exclusive license agreement for a unique COVID-19 diagnostic kit to develop and sell in the U.S., Canada and beyond.